1994
DOI: 10.1038/bjc.1994.46
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
6
0

Year Published

1994
1994
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 21 publications
(30 reference statements)
1
6
0
Order By: Relevance
“…Moreover, a direct correlation between the levels of FpT activity and the toxicity of MC has been shown for cell lines selected for resistance to this drug (27,28) and for other cell lines having different intrinsic sensitivities to MC (29). However, in each of these investigations, the activities of only one or two enzymes involved in activating the mitomycins were measured (27)(28)(29), and cell lines of different origins were compared without regard to their genetic heterogeneity (27)(28)(29). This leaves open the question as to whether other genetic changes or enzyme systems also contributed to the resistant phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, a direct correlation between the levels of FpT activity and the toxicity of MC has been shown for cell lines selected for resistance to this drug (27,28) and for other cell lines having different intrinsic sensitivities to MC (29). However, in each of these investigations, the activities of only one or two enzymes involved in activating the mitomycins were measured (27)(28)(29), and cell lines of different origins were compared without regard to their genetic heterogeneity (27)(28)(29). This leaves open the question as to whether other genetic changes or enzyme systems also contributed to the resistant phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…Both compounds retained the core mitomycin ring system but replaced the C(7) amine unit in 8 with a C(7) aminoethylene disulfide group. The compounds, 1a and 1b, exhibited improved biological profiles compared with 8, which represented 10~100-fold higher cytotoxicities in tumor cell lines (Ohe et al, 1989;Bradner et al, 1990;Ashizawa et al, 1993;Dirix et al, 1994;Xu et al, 1994;Rockwell et al, 1995), more efficient cellular uptake, and increased rates of drug accumulation in nuclei (Kono et al, 1989;Kobayashi et al, 1993b). Significantly, these compounds exhibited pharmacological activity both in 8-resistant tumor cell lines and in non-hypoxic cells (Tsuruo et al, 1990;Morimoto et al, 1991;Kobayashi et al, 1993a).…”
Section: Mitomycin Disulfidesmentioning
confidence: 98%
“…Numerous individuals with heart disease in China also take MMC (27,28). However, occurrence of resistance to MMC often limits its clinical effectiveness (12)(13)(14). To increase MMC chemotherapy sensitivity, MMC is often combined with other agents (17).…”
Section: Discussionmentioning
confidence: 99%
“…It functions by binding to the DNA of cancer cells to prevent cell division and thereby inhibit the growth of the cancer. However, its clinical effectiveness is limited bythe occurrence of resistance to MMC (12)(13)(14). To overcome this treatment resistance, MMC is often combined with other agents to increase MMC chemotherapy sensitivity (15).…”
Section: Introductionmentioning
confidence: 99%